Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults

Comments

Popular posts from this blog

‘No difference between Congress, PFI’: Karnataka BJP

2 Mangaluru businessmen in Saudi to fly 167 home